Our capabilities and experience

Read more about how we help manage complex clinical research across many therapeutic areas worldwide.

  • Resource Type

  • Services

  • Indication

  • Reset filters
Found 53 Results
Page 1 of 6
Video

40+ Years and Still no HIV Vaccine: Has Patience Been a Virtue?

The development of an HIV vaccine has been marked by both long-standing and emerging challenges and opportunities. In this video, Sanchia Theron, Global Head, Medical Affairs, and Andy Fleming, Senior Account Development Manager, discuss major takeaways from our roundtable discussion at World Vaccine Congress Washington: 40+ Years and Still no HIV Vaccine: Has Patience Been a Virtue?


Indication Overview

Our Clinical Trial Experience With Tuberculosis

The FHI Clinical project team has partnered with companies to conduct clinical trials as well as epidemiological and observational studies for tuberculosis in 30 countries worldwide.


Indication Overview

Our Clinical Trial Experience With HIV

The FHI Clinical project team has partnered with companies to conduct clinical trials as well as behavioral and observational studies for HIV in 24 countries worldwide.


Indication Overview

Our Clinical Trial Experience With Malaria

For more than 10 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in more than 35 countries worldwide.


Brochure

Our Experience in sub-Saharan Africa

FHI Clinical has long-standing relationships, a local team and broad expertise in sub-Saharan Africa. We’re ready to help you confidently expand your research across the region, finding the best-fit countries and populations for your target indication and study type.


Brochure

Vaccine Development

Vaccines are critical to the eradication of infectious diseases worldwide. To achieve the FHI Clinical vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve spent years honing our processes to respond to the urgency and complexity of vaccine trials, developing our global network of research-ready investigators and sites, and partnering with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, governments and non-governmental organizations.


Video

Global Vaccine Development

To achieve our vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve honed our processes to respond to the urgency and complexity of vaccine trials, developed our global network of investigators and sites, and partnered with organizations across public, private, academic and government sectors.


Brochure

Full-Service Global Support for COVID-19 Studies

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.


Podcast

Helping Others Achieve Their Dreams

Watch this episode of The Huxley Morton Podcast to hear our COO Rob King talk about how the skills he learned as a law enforcement officer working in the hostage and drug department help him excel in the clinical research industry.


Brochure

About FHI Clinical

FHI Clinical goes where our expertise is needed. Whether it requires working from a state-of-the-art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.